Several studies corroborate obvious down-regulation and suppressive efficacy of ATF3 in carcinogenesis, including hepatocellular carcinoma [19], prostate cancer [18], and non-small cell lung carcinoma [20]. The gene discussed is ATF3; the disease is hepatocellular carcinoma.